The results show that constitutive STAT3 phosphorylation in blood leukocytes of patients with early DMARD-naïve RA associates with disease activity, plasma levels of proinflammatory cytokines IL-6, IL-17 and IL-21, and treatment response. The gene discussed is IL17A; the disease is rheumatoid arthritis.